Amvona

Lemelson Capital featured in USA Today WWE story

 

USA todayOn March 30, 2015 Lemelson Capital was featured in USA Today crediting the firm with the timely sale of shares of World Wrestling Entertainment (NYSE: WWE) in February 2015 shortly before the shares collapsed and quoting the firm on the ongoing challenges the WWE network faces.

  • Read 4303 times
Read more...

Lantern Foundation President to Join Ecumenical Patriarchate Delegation in Constantinople for Official Visit with Pope Francis

The Lantern Foundation Logo - for linkedin 2

Official visit seeks to further strengthen relations between Vatican and 300 million-strong Eastern Orthodox Church.

BOSTON, Nov. 24, 2014 /PRNewswire-USNewswire/ -- The Lantern Foundation, a U.S.-based non-profit organization that provides financial support to Christian religious and community organizations globally, today announced that its Founder and President Fr. Emmanuel Lemelson is expected to join an official Orthodox Church delegation for the two day official visit of Pope Francis this coming week in Constantinople, Turkey.

  • Read 5235 times
Read more...

Fr. Emmanuel Lemelson Addresses Amvona Fund Holdings In Apple, World Wrestling Entertainment And Other Stocks

Fr. Emmanuel Lemelson, Chief Investment Officer of Lemelson Capital Management, general partner of The Amvona Fund, LP, and Founder and President of The Lantern Foundation, appeared on Benzinga’s “Pre-Market Prep” show on November 18, offering updated commentary on several core holdings of The Amvona Fund and discussing the mission of The Lantern Foundation, a non-profit organization he founded in 2012.

  • Read 3583 times
Read more...

Lemelson Capital Management Announces 2% Stake in Geospace Technologies (NASDAQ: GEOS)

Lemelson-Capital-Management  Logo - resized to 220 pxPlaces fair value above $78 per share

Marlborough, Mass., October 20, 2014—Lemelson Capital Management, a private investment management firm, today announced that it has taken a significant position in shares of Geospace Technologies  (NASDAQ: GEOS).  Lemelson Capital’s investment in Geospace Technologies, which will be held in the firm’s flagship Amvona Fund, represents approximately two percent of Geospace Technologies’ outstanding shares.  

  • Read 3783 times
Read more...

Lemelson Capital Management Fund Tops BarclayHedge Performance List

Lemelson-Capital-Management  Logo - resized to 220 px

The Amvona Fund Ranked World’s Top Performing Long Bias Equity Fund for August 2014

 

Marlborough, Mass., October 2, 2014—Lemelson Capital Management, a private investment management firm, today announced that BarclayHedge, a global leader in fund performance ranking and assessment, has ranked The Amvona Fund as the world’s top-performing “long bias” fund for August 2014[1]

  • Read 4562 times
Read more...

Lemelson Capital Management Marks Flagship Fund’s Second Anniversary

Lemelson-Capital-Management  Logo - resized to 220 pxThe Amvona Fund Records 160% Net Gain since September 2012 Inception, Ranking Repeatedly Among World’s Best-Performing Hedge Funds

 

Marlborough, Mass., September 5, 2014—Lemelson Capital Management, a private investment management firm, today marked the second anniversary of the launch of its flagship fund, The Amvona Fund, LP which has ranked repeatedly among the world’s top performing hedge funds.  The firm also today released the overall and net gains for the fund since inception, which were, respectively, 257.74 percent and 160.21 percent. The fund’s performance since inception has outperformed the benchmark S&P 500 Total Returns Index by 209.07 percent (111.54 percent net of all fees and expenses).

  • Read 7586 times
Read more...

Lemelson Capital Commends Kulicke and Soffa Board and Management on Share Repurchase Program

Kulicke and Soffa accepts Lemelson Capital’s April 23rd, 2014 recommendation

Marlborough, Mass., August 27, 2014—Lemelson Capital Management, a private investment management firm, today commended the Board of Directors and management team of Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) for their favorable response to Lemelson Capital’s April 23, 2014 letter to CEO Bruno Guilmart urging the company to initiate a share repurchase program. In an announcement this morning, Kulicke and Soffa said its Board of Directors has authorized a repurchase of up to $100 million of the company’s common shares, effective immediately.

  • Read 23269 times
Read more...

Ligand Pharmaceuticals (NASDAQ: LGND): Institutional holders wasting no time dumping stock in response to mounting insolvency and bankruptcy risks

Ligand’s largest Shareholder BVF, Inc. sells 484,524 shares

A PDF version of the report is available here

Overview 

Raising prospects for a continued deterioration in the stock price of Ligand Pharmaceuticals (NASDAQ: LGND), the largest shareholder in the company has moved to unload shares of the troubled company in a private transaction.   Earlier this week, on August 19, BVF, Inc., the company’s largest shareholder, offloaded 484,524 shares in a private transaction, the terms of which are both costly and indicative of institutional sentiment.

  • Read 7367 times
Read more...

Lemelson Capital Says Ligand Pharmaceuticals’ (NASDAQ: LGND) $225M Debt Issuance Solidifies Company’s Insolvency, Substantially Raises Specter of Bankruptcy

Lemelson Capital short stake built as share price collapses on insolvency and bankruptcy risk

Rev. Father Emmanuel Lemelson, Founder and President of the Lantern Foundation and Chief Investment Officer of Lemelson Capital Management, appeared yesterday on Benzinga’s Pre-Market Prep show in which he addressed recent geopolitical and global market developments and the firm’s existing long and short investment positions, including Lemelson Capital’s short position in Ligand Pharmaceuticals (NASDAQ: LGND), which the firm first announced on June 16, 2014. Lemelson Capital has continued to sell the stock short even as its share price has collapsed over the last six weeks.

  • Read 16239 times
Read more...

Don't
Hesitate To
Contact Us

 

145 Pine Haven Shores Road
Suite 2293
Shelburne, VT 05482

Feel free to email us. We would be happy to answer any questions you might have.


Copyright © 2019 Amvona